demonstrated that radiotherapy combined with macrophage depleting agents enhanced tumor killing and found that colorectal (MC38) and pancreatic (KPC) cell lines produced CSF-1 after irradiation, leading to an increase in M2 macrophages, which were immunosuppressive in tumors. The gene discussed is CSF1; the disease is neoplasm.